Impact of Etrasimod on Blood Pressure and Hypertension: Data From the Etrasimod Ulcerative Colitis Clinical Program

被引：0

作者：

Vermeire, Severine ^{[1
]}

Rubin, David T. ^{[2
]}

Peyrin-Biroulet, Laurent ^{[3
,4
]}

Dubinsky, Marla C. ^{[5
]}

Regueiro, Miguel ^{[6
]}

Irving, Peter M. ^{[7
]}

Goetsch, Martina ^{[8
]}

Lazin, Krisztina ^{[8
]}

Wu, Joseph ^{[9
]}

Modesto, Irene ^{[10
]}

Woolcott, John C. ^{[11
]}

McDonnell, Aoibhinn ^{[12
]}

Rabbat, Christopher J. ^{[10
]}

Yarur, Andres J. ^{[13
]}

机构：

[1] Univ Ziekenhuis Leuven, Leuven, Vlaams Brabant, Belgium

[2] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA

[3] Lorraine Univ, Last Inserm U954, Vandoeuvre Les Nancy, Lorraine, France

[4] Lorraine Univ, CHU Nancy, Vandoeuvre Les Nancy, Lorraine, France

[5] Mt Sinai Kravis Childrens Hosp, New York, NY USA

[6] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH USA

[7] Guys & St Thomas Natl Hlth Serv Fdn Trust, London, England

[8] Pfizer AG, Zurich, Switzerland

[9] Pfizer Inc, Cambridge, MA USA

[10] Pfizer Inc, New York, NY USA

[11] Pfizer Inc, Collegeville, PA USA

[12] Pfizer Ltd, Sandwich, Kent, England

[13] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S905

引用

页码：S675 / S675

页数：1

共 50 条

[31] ETRASIMOD FOR THE TREATMENT OF ULCERATIVE COLITIS: ANALYSIS OF INFECTION RATES FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 CLINICAL TRIALS
Regueiro, Miguel D.
Siegmund, Britta
Yarur, Andres J.
Steinwurz, Flavio
Gecse, Krisztina
Goetsch, Martina
Bhattacharjee, Abhishek
Wu, Joseph
Green, Jesse
McDonnell, Aoibhinn
Crosby, Catherine
Lazin, Krisztina
Branquinho, Diogo
Modesto, Irene
Abreu, Maria T.
GASTROENTEROLOGY, 2023, 164 (06) : S1105 - S1106
[32] Etrasimod for the treatment of ulcerative colitis: analysis of infection rates from the phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trials
Regueiro, M.
Siegmund, B.
Yarur, A.
Steinwurz, F.
Gecse, K. B.
Goetsch, M.
Bhattacharjee, A.
Wu, J.
Green, J.
McDonnell, A.
Crosby, C.
Lazin, K.
Branquinho, D. Ferreira
Modesto, I.
Abreu, M. T.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 689 - 690
[33] Etrasimod as a Monotherapy or With Concomitant Use of Corticosteroids and/or Aminosalicylates: Results From the ELEVATE UC Clinical Program
Yarur, Andres J.
Chiorean, Michael, V
Allegretti, Jessica R.
Cross, Raymond K.
Ha, Christina
Goetsch, Martina
Mcdonnell, Aoibhinn
Dalam, Alexis B.
Wu, Joseph
Blanco, David A.
Abbatemarco, Arcangelo M.
Panes, Julian
INFLAMMATORY BOWEL DISEASES, 2024,
[34] Efficacy and Safety of Etrasimod in Patients with Ulcerative Colitis in Japan: Data from the Phase 3 ELEVATE UC 12 and ELEVATE UC 40 JAPAN Trials
Takeuchi, Ken
Hisamatsu, Tadakazu
Nakase, Hiroshi
Matsuoka, Katsuyoshi
Keating, Michael
Yuasa, Hirotoshi
Oe, Motoki
Arai, Shoko
Mazur, Rafal
Hibi, Toshifumi
DIGESTION, 2024,
[35] Health-Related Quality of Life From the Inflammatory Bowel Disease Questionnaire in Patients with Ulcerative Colitis Stratified by Prior & Concomitant Therapies: Results From the Etrasimod ELEVATE UC Clinical Program
Armuzzi, Alessandro
Rubin, David T.
Schreiber, Stefan
Panes, Julian
Fellmann, Marc
Bartolome, Lauren
Goetsch, Martina
Bhattacharjee, Abhishek
Wu, Joseph
Chaparro, MariIa
Dubinsky, Marla C.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S683 - S684
[36] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
Vermeire, Severine
Chiorean, Michael
Panes, Julian
Peyrin-Biroulet, Laurent
Zhang, Jinkun
Sands, Bruce E.
Lazin, Krisztina
Klassen, Preston
Naik, Snehal U.
Cabell, Christopher H.
Sandborn, William J.
JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
[37] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
Chiorean, Michael
Vermeire, Severine
Panes, Julian
Peyrin-Biroulet, Laurent
Zhang, Jinkun
Sands, Bruce E.
Lazin, Krisztina
Cabell, Chris H.
Naik, Snehal U.
Klassen, Preston
Sandborn, William J.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
[38] ETRASIMOD SHOWS LOW RISK OF ADVERSE EVENTS FOLLOWING CONCOMITANT USE WITH OPIOIDS OR ANTIDEPRESSANTS IN PATIENTS WITH ULCERATIVE COLITIS
Afzali, Anita
Regueiro, Miguel D.
Yarur, Andres J.
Zabana, Yamile
Ng, Siew C.
Menon, Sujatha S.
McDonnell, Aoibhinn
Lazin, Krisztina
Keating, Michael
Bhattacharjee, Abhishek
Branquinho, Diogo
Bananis, Eustratios
Peyrin-Biroulet, Laurent
GASTROENTEROLOGY, 2024, 166 (05) : S818 - S818
[39] Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program
Sands, Bruce E.
Dubinsky, Marla C.
Kotze, Paulo G.
Vermeire, Severine
Panaccione, Remo
Long, Millie D.
Woolcott, John C.
Wu, Joseph
Mcdonnell, Aoibhinn
Goetsch, Martina
Bananis, Eustratios
Yarur, Andres J.
INFLAMMATORY BOWEL DISEASES, 2025,
[40] Etrasimod shows low risk of adverse events following concomitant use with opioids or antidepressants in patients with ulcerative colitis
Afzali, A.
Regueiro, M.
Yarur, A. J.
Zabana, Y.
Ng, S. C.
Menon, S. S.
McDonnell, A.
Lazin, K.
Keating, M.
Bhattacharjee, A.
Branquinho, D.
Bananis, E.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1026 - I1027

← 1 2 3 4 5 →